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Structural studies showed that Dnmt3a has two interfaces for
protein-protein interaction in the heterotetrameric Dnmt3a/3L
C-terminal domain complex: the RD interface (mediating the
Dnmt3a-3a contact) and the FF interface (mediating the
Dnmt3a-3L contact). Here, we demonstrate that Dnmt3a-C
forms dimers via the FF interface as well, which further olig-
omerize via their RD interfaces. Each RD interface of the
Dnmt3a-C oligomer creates an independent DNA binding site,
which allows for binding of separateDNAmolecules oriented in
parallel. Because Dnmt3L does not have an RD interface, it pre-
vents Dnmt3a oligomerization and binding of more than one
DNAmolecule. Both interfaces of Dnmt3a are necessary for the
heterochromatic localization of the enzyme in cells. Overex-
pression of Dnmt3L in cells leads to the release of Dnmt3a from
heterochromatic regions, which may increase its activity for
methylation of euchromatic targets like the differentially meth-
ylated regions involved in imprinting.
The coordinated gene expression during development and
cell differentiation is regulated by epigenetic signals comprising
DNA methylation, post-translational modification of histone
tails, and non-coding RNAs (1). Among them, DNA methyla-
tion is a key epigenetic process involved in the control of gene
activity (2–3), parental imprinting (4–6), X-chromosome inac-
tivation (7–10), and maintenance of the genome integrity and
stability through protection against endogenous retroviruses
and transposons (11). Aberrant DNA methylation patterns are
associated with several human diseases, including cancer (12–
17). In mammals, DNA methylation patterns are established
during embryogenesis by the action of the de novoDNAmeth-
yltransferases Dnmt3a and Dnmt3b, together with their regu-
latory factor, Dnmt3L (18–19). In addition, the Dnmt3a and
Dnmt3b enzymes have a role in the preservation of DNAmeth-
ylation at heterochromatin regions (20–21). Disruption of the
Dnmt3a or Dnmt3b gene in mice is lethal (22), whereas
Dnmt3L knock-out mice are viable and do not show discern-
able morphological abnormalities (23–25), indicating that
Dnmt3a and Dnmt3b are functional in the absence of Dnmt3L.
Dnmt3a andDnmt3b are nuclear proteins, which stably asso-
ciate with chromatin containing methylated DNA (21), includ-
ing mitotic chromosomes, and localize to pericentromeric het-
erochromatin (26–28). Dnmt3 proteins comprise two parts: a
large multidomain N-terminal part of variable size, which has
regulatory and targeting functions and a C-terminal catalytic
part. TheN-terminal part ofDnmt3a andDnmt3b contains two
defined domains: a cysteine-rich ADD (ATRX–DNMT3–
DNMT3L) domain, which binds to H3 tails unmodified at K4
(29–30) and a PWWP domain, which binds to H3 trimethy-
lated at K36 (31) and is essential for the heterochromatin local-
ization of the enzymes (27–28, 31). The C-terminal parts of
Dnmt3 enzymes resemble prokaryotic DNA-(cytosine C5)-
methyltransferases and harbor the active centers of the
enzymes and are active in an isolated form (32). Dnmt3L is
catalytically inactive, directly interacts with the catalytic
domains of Dnmt3a and Dnmt3b and stimulates their activity
both in vivo and in vitro (25, 33–37).
The structure of a complex consisting of theC-terminal parts
of Dnmt3a and Dnmt3L (Dnmt3a-C/Dnmt3L-C) revealed a
linear heterotetramer, in which the two Dnmt3L subunits are
positioned at the edges and two Dnmt3a molecules in the cen-
ter (Fig. 1A) (38–39). TheDnmt3aC-terminal domain provides
two interfaces for protein-protein contacts: one hydrophobic
FF interface at the Dnmt3a-C/3L-C contact formed by the
stacking interaction of four phenylalanine residues (two from
each subunit) and one polar RD interface at the Dnmt3a-C/
3a-C contact mediated by a hydrogen bonding network be-
tween arginine and aspartate residues. The RD interface forms
the DNA binding site, while both interfaces are essential for
cofactor S-adenosyl-L-methionine binding and catalytic activ-
ity of the enzyme (38, 40).Wedemonstrate here thatDnmt3a-C
oligomerizes in a reversible manner. Initial dimer formation
occurs through the FF interface, further oligomerization via the
RD interface of the FF dimers. Because each RD interface con-
stitutes an independent DNA binding site, Dnmt3a-C oligo-
mers can bind to two ormore DNAmolecules, oriented next to
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each other, roughly in parallel. Dnmt3L prevents this oligomer-
ization, because it lacks the RD interface, and it therefore pre-
cludes binding of Dnmt3a to more than one DNA molecule.
The formation of Dnmt3a oligomers is required for the local-
ization of the enzyme to heterochromatin, and binding of
Dnmt3L changes the subnuclear localization of Dnmt3a, which
could be one mechanism describing how Dnmt3L stimulates
the methylation of imprinted loci.
EXPERIMENTAL PROCEDURES
Mutagenesis, Protein Expression, and Protein Purification—
The sequences encoding C-terminal domains of the murine
Dnmt3a (residues 608–908) and Dnmt3L (residues 208–421)
were subcloned as N-terminal His6 fusion proteins into pET-
28a vector (Novagen) (32, 36). Selected Dnmt3a-C and
Dnmt3L-C variants were generated using the megaprimer site-
directed mutagenesis method as described previously (41).
Introduction of the mutations was confirmed by restriction
marker site analysis and DNA sequencing. Protein expression
was carried out in Escherichia coli BL21 (DE3) pLysS (Nova-
gen). Cells were grown at 32 °C, induced with 1 mM IPTG at
A600 nm of approximately 0.5 and harvested after 3 h. The pro-
teins were purified at high M concentrations using Ni-NTA-
agarose. Each protein was purified at least twice, and the purity
of the preparations was estimated to be greater than 98% (sup-
plemental Fig. S4A). The concentrations of the proteins were
determined by UV spectrophotometry using extinction coeffi-
cients of 39290 M1 cm1 and 40330 M1 cm1 for Dnmt3a-C
and Dnmt3L-C, respectively. Concentration determinations
were confirmed by densitometric analysis of Coomassie-
stained SDS-polyacrylamide gels. The folding of the mutant
proteins was verified by circular dichroism spectroscopy as
described (42), indicating that the secondary structure of
the R881A variant was indistinguishable from wild-type
Dnmt3a-C. The F728 variants were both folded as demon-
strated by the strong negative ellipticity at 220 nm, which is
indicative of -helix content (supplemental Fig. S4B). Both
F728 variants displayed a small but significant shift in the
ascending limb of the spectrum around 200 nm, suggesting
some deviations from the wt folding. The aggregation of
Dnmt3a-C shown in Fig. 2A and supplemental Fig. S1A and
recovery of enzyme activity from aggregated Dnmt3a-C was
only done for illustration. All other experiments reported in
this study were conducted with Dnmt3a-C proteins that never
went through aggregation, because they were purified at lower
protein concentration.
Analytical Ultracentrifugation—Analytical ultracentrifuga-
tion was done with an An50-Ti 8-place rotor in a Beckman-
Coulter model XL-A centrifuge equipped with UV absorption
optics. Sedimentation velocity experiments were run at 4 °C
and 50 krpm in a buffer containing 10 mMHEPES pH 7.2, 0.2 M
KCl, 1.34 M glycerol (10%), 1mMEDTA, and 0.2mMDTT. They
were evaluated using the program SEDFIT, which transforms
the measured data into a diffusion corrected differential sedi-
mentation coefficient distribution (43–44). For every sedi-
menting species the sedimentation constant was read off the
corresponding maximum of this distribution. All distributions
were corrected towater at 20 °Cusing density and viscosity data
and partial specific volumes incorporated into SEDNTERP.4
Fluorescence Spectroscopy—Fluorescence spectroscopy was
carried out in a Cary Eclipse fluorimeter (Varian) using a dou-
ble-labeled two flank oligonucleotide substrate obtained by
annealing of three individual oligonucleotides, one 50mer that
could hybridize with two 20mers (one of them labeled by Cy3,
one by Cy5): 50mer: 5-TGC ACT CTC CTC CCG GAA GTG
TTC TTC GTA GAC TGC GGC ACA GTT TTTTG-3; Cy3–
20-L: 5-ACT TCC GGG AGG AGA GTG CA-3-Cy3; Cy5–
20-R: Cy5–5-CAAAAAACTGTGCCGCAGTC-3. Control
4 D. B. Hayes, T. Laue, and J. Philo, unpublished data.
FIGURE 1. Models of Dnmt3a-C/3L-C heterotetramer and Dnmt3a-C olig-
omers in complex with DNA. A, model of the Dnmt3a/Dnmt3L C-terminal
domain tetramer, colored in green for Dnmt3a-C and in cyan for Dnmt3L-C.
The cofactor S-adenosyl-L-methionine is shown in yellow and the modeled
DNA in blue. The close up of the FF and RD interfaces is shown with the
relevant amino acid residues labeled. B and C, modeling of Dnmt3a-C oligo-
mers formed by the interaction of FF-dimers via their RD interface. The figure
shows a hexameric complex as an example; the three FF-dimeric building
blocks are colored light green and dark olive green. The two DNA molecules
bound at the RD interfaces in the Dnmt3a-C hexamer are oriented roughly in
parallel. Panel B shows a view along the axis of the bound DNA molecules,
panel C shows a view perpendicular to the axis of the Dnmt3a oligomer.
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substrates only containing the Cy3 or Cy5 probe were gener-
ated using unlabeled versions of the 20mers. 20-L: 5-ACTTCC
GGG AGG AGA GTG CA-3; 20-R: 5-CAA AAA ACT GTG
CCG CAG TC-3.
TheDNA substrate used for Fluorescence Resonance Energy
Transfer (FRET)5 experimentswas obtained by annealing of the
50mer with one 20-L and one 20-R oligonucleotide. It provides
two double-stranded 20 bps stretches, which are separated by a 10
nucleotide single-stranded part, and contain either two (Cy3 and
Cy5) or one fluorophore (only Cy3 or only Cy5) (Sequence 1).
The FRET DNA was annealed by mixing all three individual
strands at equal concentration (20 M), heating to 86 °C for 5
min, and slowly cooling to ambient temperature. The annealed
substrate was purified using Qiagen nucleotide purification kit.
FRET experiments were carried out in the presence and
absence of Dnmt3a-C proteins in buffer (20mMHEPES pH 7.5,
1 mM EDTA, 100 mM KCl) containing 100 nM FRET DNA. For
the protein-bound sample, 200 nM Dnmt3a-C proteins com-
plex were added and incubated with the DNA at ambient tem-
perature for 20 min to allow for complex formation. The 3a/3L
complex was prepared by incubation of Dnmt3a-C and
Dnmt3L-C (final concentration of 200 nM each) on ice for 20
min prior to the incubation with DNA. FRET was studied by
using Cy3 excitation at 540 nm. Cy5 excitation in control reac-
tion was at 640 nm. Emission and excitation slits were always
set at 5 nm. In all experiments, 5 separate scans were taken and
averaged. All experiments were carried out at least in duplicate;
usually 3–4 repeats were performed.
Scanning-force Microscopy—Scanning force microscopy
(SFM) experiments were carried out using a 509mer DNA frag-
ment derived from the human CG island upstream of the
human SUHW1 gene and purified catalytic domains of
Dnmt3a. DNA-protein filaments were generated in a total vol-
ume of 30 l by incubating 12 nM DNA with 200 nM Dnmt3a
protein in 50 mM HEPES (pH 7.5), 250 mM NaCl, 1 mM EDTA,
and 100 M of sinefungin (Sigma). Samples were incubated for
1 h at room temperature to allow for DNA binding. 1 l of the
complex solutionwasmixedwith 9l of 10mMMgCl2 solution
anddeposited on freshly cleavedmica (Plano,Wetzlar), allowed
to adhere for 40 s and then washed with 1 ml of bi-distilled
water. The sample was then dried using compressed air. Pro-
tein-DNA filaments where observed by tapping mode in air
using a Multimode AFM with a Nanoscope III controller (Dig-
ital instruments, Santa Barbara, CA). We used NSTNCHF sili-
con cantilevers (Nascatec, Stuttgart) with a nominal spring
constant of 50N/mand a resonance frequency of150 kHz.All
images were obtained with a scanning speed of 0.75–1Hz and a
resolution of 512  512 pixels. Experiments were carried out
blinded, i.e. the operator of the microscope did not know the
data obtained in prior experiments. To remove background
slope, raw imageswere flattened using theNanoscope software.
DNA protein complexes were regarded as a filament if the
height exceeded 150%of the height observed forDNAmolecule
alone and were at least 20 nm wide. Filaments were evaluated
using the section tool of the Nanoscope V6r12 software.
Cell Culture and Laser Scanning Microscopy—The expres-
sion construct for murine full length Dnmt3a fused to yellow
fluorescent protein (YFP) was obtained fromDr. G. Xu (Shang-
hai) (45). To prepare a cyan fluorescent protein (CFP) fusion of
Dnmt3L, human full-length Dnmt3L (AP001753) was cloned
into the pECFP-C1 vector (Invitrogen), using XhoI and EcoRI
sites. The interface variants of full length Dnmt3a and Dnmt3L
were created in a similar way as the interface variants of the
C-terminal domains (see above). NIH3T3 cells were grown in
DMEMwith 10% (v/v) fetal calf serum and 2mM L-glutamine at
37 °C in 5% (v/v) CO2. Cells (1–2  105) were transfected in
6-well plates using FuGENE 6 (Roche, Basel, Switzerland; 1 g
of total plasmid DNA per well). In co-transfection experiments
equal amounts of Dnmt3a-YFP and Dnmt3L-CFP encoding
plasmids were used. TransfectedNIH3T3 cells were fixed in 4%
(w/v) paraformaldehyde. Confocal images were taken using a
Carl Zeiss LSM510 (Jena, Germany; software version 3.0). For
the analysis of the co-transfection experiments, the observed
localization pattern of Dnmt3a was divided into three catego-
ries: spotty, spotty plus diffused and diffused; 100, 54, or 73 cells
were analyzed for the Dnmt3a wt, Dnmt3a-Dnmt3L wt, and
Dnmt3a-Dnmt3L F261D mutant, respectively.
RESULTS
Oligomerization of Dnmt3a-C Depends on Both Interfaces
and Is Disrupted by Dnmt3L-C—We have noticed for several
years, that Dnmt3a-C tends to aggregate during purification at
the dialysis step when the salt concentration is reduced from
500 to 200mMKCl if the protein concentration is too high (Fig.
2A and supplemental Fig. S1A). Recently, we observed that the
aggregated enzyme preparations could be re-dissolved after
dilution and then display almost 80% of the catalytic activity of
an enzyme preparation that never went through aggregation
(supplemental Fig. S1B). The observation that recovery of
enzyme activity did not require refolding indicates that the
aggregation process is reversible, and it probably occurs
through native protein/protein interfaces. The structure of
the Dnmt3a-C/3L-C tetramer shows that Dnmt3a-C has two
such interfaces (Fig. 1A), the FF and RD interface. The con-
servation of key residues of the FF interface between all
members of the Dnmt3 family (supplemental Fig. S2), as well
as modeling, suggested that Dnmt3a could replace Dnmt3L
at the Dnmt3a-3L interface (the FF interface) to form
another Dnmt3a/3a contact. Hence, the C-terminal domain
of Dnmt3a possesses two putative interfaces for self-interac-
tion, leading to the possibility of forming linear Dnmt3a-C
oligomers (Fig. 1, B and C and supplemental Fig. S2B).
Dnmt3a-C precipitation experiments in the presence of
Dnmt3L-C showed that Dnmt3L-C considerably reduced
5 The abbreviations used are: FRET, fluorescence resonance energy transfer;
YFP, yellow fluorescent protein; CFP, cyan fluorescent protein; SFM, scan-
ning force microscopy.
SEQUENCE 1. FRET DNA Substrate.
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aggregation of Dnmt3a-C (Fig. 2A and supplemental Fig.
S1A). The amino acid sequence alignment of Dnmt3a and
Dnmt3L shows that Dnmt3L-C lacks an RD interface (sup-
plemental Fig. S2A), suggesting that the RD interface plays
an important role in the reversible aggregation of Dnmt3a-C.
This conclusion is also in agreement with the salt depend-
ence of the aggregation, because the RD interface is domi-
nated by ionic contacts which strengthen during reduction
of salt concentration.
Using analytical ultracentrifugation, we investigated in detail
the oligomeric state of the purified wild type Dnmt3a-C that
never went through aggregation. The experiment revealed one
fraction sedimenting with an S20 °C,water-value of 4.5–4.6 S (Fig.
2B), which corresponds to a dimer with a frictional ratio of
1.35–1.4. The frictional ratio of a folded protein lies between
1.2 for a globular structure and 1.5–1.7 for extended or elon-
gated structures (46). A second, major fraction of Dnmt3a-C
sedimented at higher S values (6–6.2 S) corresponding to a
Dnmt3a-C tetramer with elongated structure (frictional ratio
1.6 0.3). Higher aggregates were also observed, depending on
the initial concentration of the preparation. In contrast, in
ultracentrifugation experiments with purifiedDnmt3a-C/3L-C
complex at comparable concentrations only the 2:2 heterote-
tramer of 5.4 S was detected (40), indicating that Dnmt3L-C
prevents oligomerization of Dnmt3a-C. These observations are
in agreement with published data obtained with Dnmt3a2, an
isoformofDnmt3a also containingmost of theN-terminal part,
showing that Dnmt3A2 forms large structures of heterogene-
ous sizes, although binding ofDnmt3L toDnmt3A2 leads to the
formation of specific heterotetrameric complexes (37). To ana-
lyze the potential self-interaction of Dnmt3L-C via its FF inter-
face, purified Dnmt3L-C was also studied by analytical ultra-
centrifugation and showed a sedimentation constant of 2.35 S,
which corresponds to a monomeric state with a frictional ratio
of 1.35 (supplemental Fig. S3).
To study the role of the interfaces in Dnmt3a function, we
mutated the Arg-881 at the RD interface to alanine (R881A)
and the Phe-728 at the FF interface to alanine (F728A) and to
aspartic acid (F728D), assuming that the F to D exchange,
which introduces a charged residue instead of a hydrophobic
one, would result in a stronger phenotype than the F toAmuta-
tion. The protein variants were expressed, purified and their
folding confirmed by circular dichroism spectroscopy (supple-
mental Fig. S4). As expected, DNA binding experiments
showed that the RD interface constitutes the DNA binding site
of Dnmt3a-C homooligomers, because the R881A exchange
abrogated DNA binding, while the F728A and F728D variants
bound DNAwith even slightly better affinity than the wild type
enzyme (supplemental Fig. S5). These results replicate previous
observations made with the corresponding heterotetrameric
Dnmt3a-C/3L-C complexes (40). We have also shown before
that all three Dnmt3a-C variants are catalytically inactive (40).
In the ultracentrifugation experiments, the Dnmt3a-C
R881A mutant retained its ability to dimerize (S20 °C,water 
4.3–4.4 S) (Fig. 2B). However, tetramers as observed for the
wild type protein were not detected. The dimeric state of the
R881Amutant demonstrates that the FF interface is fully func-
tional and mediates dimerization of Dnmt3a. In contrast, the
F728D mutation converted the protein into a monomer
(S20 °C,water  2.6–2.7 S, frictional ratio 1.5, Fig. 2C), indicating
that the intact RD interface does not support self-interaction in
absence of DNA. The efficient DNA binding of the FF variants
suggests that dimerization across the RD interface can occur in
presence of DNA, because DNA binding requires the coopera-
tion of both subunits at the RD interface (38). The Dnmt3a-C
F728A variant behaved as a dimer (data not shown), indicating
that the F to A exchange did not fully disrupt the FF interface,
such that dimerizationwas still possible under the conditions of
the analytical ultracentrifugation, which was performed at rel-
atively high protein concentrations.
Taken together, we show that the FF interface is the primary
interface for Dnmt3a-C homodimerization, because the R881A
mutant retained its ability to dimerize (via the FF interface),
whereas the F728Dmutation converted the dimer into amono-
mer. This finding is in agreement with the structure, because
the FF interface is hydrophobic while the RD interface is hydro-
philic in nature, and hydrophobic protein/protein interfaces
are known to be more stable (47–48). Further reversible oligo-
merization of Dnmt3a-C is mediated by the salt-dependent
interaction of Dnmt3a-C FF dimers via their RD interfaces.
This process is prevented by Dnmt3L-C, because it does not
contain an RD interface. The requirement for the Dnmt3a-C
homodimer to first dissociate before Dnmt3L-C/3a-C com-
plexes can form also explains the long preincubation times of
separately purified Dnmt3a-C and Dnmt3L-C needed to reach
a maximum stimulation of Dnmt3a-C activity (37). The forma-
tion of Dnmt3a-C/3L-C complexes is supported by the mono-
meric state of Dnmt3L-C.
Binding of Parallel DNA Molecules by Dnmt3a-C Oligomers—
Wemodeled the structure of a Dnmt3a-C/3a-C contact via the
FIGURE 2. Oligomerization of Dnmt3a-C. A, reversible aggregation of
Dnmt3a-C during protein purification is prevented in the presence of
Dnmt3L-C. The figures show samples of Dnmt3a-C (40 M) or Dnmt3a-C/3L-C
(40 M each) after reduction of salt concentration from 500 mM KCl to 200 mM
KCl by 2 h of dialysis. B and C, differential sedimentation coefficient (S20 °C,W)
distributions obtained from sedimentation velocity experiments in the ana-
lytical ultracentrifuge with Dnmt3a-C wt (2B, red), R881A (2B, blue) and F728D
(2C) mutants.
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FF interface by superimposing aDnmt3a-C subunit onto one of
the Dnmt3L-C molecules of the Dnmt3a-C/3L-C heterote-
tramer structure. This superposition can be done with good
confidence, because of the strong structural and amino acid
sequence similarity between Dnmt3a-C and Dnmt3L-C. By
combining these Dnmt3a-C/3a-C FF dimers obtained by mod-
eling with Dnmt3a-C/3a-C dimers formed via the RD interface
taken from the Dnmt3a-C/3L-C structure, a model of a
Dnmt3a-C hexamer containing three FF and two RD interfaces
could be generated. In principle, this hexamer could be further
extended. Because each RD interface constitutes an indepen-
dent DNA binding site, such a hexamer could bind two DNA
molecules (Fig. 1,B andC). Interestingly, themodeling suggests
that the DNA binding sites are oriented roughly in parallel to
each other in a distance of3–4 nm,whichwould not allow for
one DNAmolecule to bind side by side to both sites simultane-
ously. Instead, binding of twoDNAmolecules oriented roughly
in parallel to each other could occur (Fig. 1, B and C and sup-
plemental Fig. S2B).
To study the potential binding of two parallel DNA mole-
cules by the Dnmt3a-C oligomer in solution, we developed a
FRET assay, using a DNA substrate that consists of two 20 base
pair double-stranded regions separated by a 10 nucleotide sin-
gle-stranded region, which are flexible. The ends of the DNA
were labeled with fluorophores that constitute a FRET donor/
acceptor pair (Cy3/Cy5 with a Förster radius of about 56 Å). In
the annealed oligonucleotide, the average distance of both ends
is large and does not permit FRET. However, after binding of
the FRET substrate to adjacent RD interfaces of a Dnmt3a-C
oligomer, the ends should approach each other, and FRET
could be established (Fig. 3A). Indeed, with the free DNAonly a
small Cy5 signal was observed after excitation of Cy3 at 540 nm
(Fig. 3B). This signal does not correspond to FRET, but could be
attributed to direct excitation of Cy5 (data not shown). How-
ever, after addition of Dnmt3a-C to the FRET substrate, we
observed a strong increase in Cy5 fluorescence after Cy3 exci-
tation, which is indicative of FRET (Fig. 3B). Control experi-
ments confirmed that an increase in Cy5 fluorescence after
addition of Dnmt3a-C was not observed after direct excitation
of Cy5 (data not shown) and with identical substrates that only
contained the Cy3 or Cy5 probe (Fig. 3C). These controls con-
firm that FRET is detected and parallel DNA binding occurs.
Next we investigated the effect of Dnmt3L-C on parallel DNA
binding ofDnmt3a-C.A strongly reduced FRET signal was seen
after addition of a Dnmt3a-C/3L-C complex when compared
with Dnmt3a-C at same concentration. The Dnmt3a-C/3L-C
complex was generated by preincubation of Dnmt3a-C and
Dnmt3L-C. Under these conditions, it is unlikely that all
Dnmt3a-C oligomers are resolved, which explains the residual
FRET effect that was still observed. The FRET signal was also
lost with the Dnmt3a-C mutants that disrupt the FF interface,
such that DNA binding is possible, but no oligomerization of
Dnmt3a-C occurs (Fig. 3C). These results confirm that
Dnmt3a-C oligomers can bind to two DNAmolecules oriented
in parallel. Dnmt3L-C or mutations at the FF interface of
Dnmt3a-C disrupt the oligomers and, thereby, prevent parallel
binding of more than one DNA molecule.
Next, we studied the binding of long DNA molecules to
Dnmt3a-C oligomers by SFM. We have shown previously that
theDnmt3a-C/3L-C complex polymerizes onDNA, using puri-
fied Dnmt3a-C and a 509 bp PCR product, which can be visu-
alized accurately by SFM (40). We now observed that
Dnmt3a-C forms DNA-nucleoprotein filaments in the absence
of Dnmt3L as well (Fig. 4). However, additional structural fea-
tures like sharp curvatures and lariats were also seen with
Dnmt3a-C, indicating that protein bound stretches fromdifferent
parts of a long single DNA molecule can interact after forming
DNAloops (Fig. 4C). Interestingly, aboutone thirdof theobserved
complexes contained two DNAmolecules connected by more or
less extended protein-DNA filaments (Fig. 4D). These connected
synaptonemal-like complexes were probably formed by a direct
interaction between Dnmt3a-C molecules bound to different
DNA molecules oriented in parallel (Fig. 4E). Such complexes
were not observed in the previous Dnmt3a-C/3L-C experiments.
They document the ability of Dnmt3a-C oligomers to bind simul-
taneously to two DNAmolecules oriented in parallel.
FIGURE 3. Analysis of binding of parallel DNA molecules by Dnmt3a-C oligomers. A, schematic setup of the FRET assay. In free form, the distance of both
ends of the FRET substrate is too large for FRET to occur. After binding of the two double-stranded regions to adjacent DNA binding sites in a Dnmt3a-C
oligomer, the ends approach each other and FRET can be established. B, fluorescence emission spectra of the free FRET DNA (black line) and of FRET DNA-
Dnmt3a-C complexes (grey line) after Cy3 excitation. FRET is indicated by the strong increase in Cy5 emission at 665 nm in the presence of Dnmt3a-C. C, Cy5
emission of the FRET DNA after addition of Dnmt3a-C, Dnmt3a-C interface variants or Dnmt3a-C/3L-C complex divided by the corresponding Cy5 emission of
the FRET obtained for free DNA. In addition, as a control, experiments with single labeled FRET DNA (either only carrying Cy3 or Cy5 label) were carried out, but
no signal change was observed after addition of Dnmt3a-C. Excitation was at 540 nm. Error bars represent the error of the mean derived from the variation of
repeated experiments.
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Subnuclear Localization of Dnmt3a Depends on Both Inter-
faces and Is Altered by Dnmt3L—It had been shown before that
Dnmt3a localizes to heterochromatic foci in mouse cell lines
(26–28, 31) and that this effect depends on both the PWWP
and the catalytic domain of Dnmt3a (27–28, 31). To investigate
if oligomerization of Dnmt3a has an effect on its cellular and
subnuclear localization, we studied the cellular distribution of
YFP-tagged full-length Dnmt3a and its interface mutants
R881A, F728A, and F728D in NIH 3T3 cells. As expected, wild
type Dnmt3a was located exclusively in subnuclear spots (Fig. 5
FIGURE 4. Scanning force microscopy of Dnmt3a-C-DNA filaments. A, images showing free DNA. B–D, images showing examples of Dnmt3a-DNA filaments.
Regular filaments (B), structures like lariats and sharp curvatures (C), as well as branched, synaptonemal-like complexes (D) can be observed. E, magnification
of an exemplary picture from D and a schematic representation of a DNA oligomer bound to two parallel DNA molecules. The scale bars correspond to 50 nm.
FIGURE 5. Subnuclear localization of Dnmt3a and Dnmt3L. A, localization of the YFP-tagged full-length Dnmt3a wt and its interface variants R881A, F728A
and F728D in NIH3T3 cells. B, localization of the YFP-tagged full-length Dnmt3a wt in NIH3T3 cells in the presence and absence of Dnmt3L. Three patterns of
nuclear localization were observed: diffused, spotty plus diffused and spotty. The bar diagram shows a quantification of the Dnmt3a localization in the
presence and absence of Dnmt3L wt. Additional experiments were conducted with the Dnmt3L F261D interface mutant that partially lost its ability to interact
with Dnmt3a. The blue bars represent cells with spotty Dnmt3a localization, the orange bars spotty plus diffused, and the gray bars correspond to diffused
localization pattern. The scale bars represent 5 m.
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and supplemental Figs. S6 and S7), which were previously
shown to co-localize with pericentromeric heterochromatin
and reflect the localization of the endogenous enzyme (26–28,
31). The F728A, F728D, and R881A variant fusion proteins
showed similar expression levels as the wild type protein (as
judged by the intensity of the fluorescence signal) and exclusive
nuclear localization as well. However, all variants displayed a
great change in the sub-nuclear localization pattern. Instead of
the enrichment in distinct heterochromatic spots characteristic
of the wild-type protein, a diffuse staining was observed, with
the fluorescence signal almost uniformly distributed within the
nucleus (Fig. 5A). These results indicate that the ability of
Dnmt3a to bind to heterochromatic regions was lost or greatly
reduced with the interface mutants indicating that both inter-
faces are required for the stable localization of Dnmt3a to the
heterochromatic foci. A similar change in localization was
observed after complete removal of the catalytic domain of
Dnmt3a (27).
We next investigated the subuclear localization of CFP-fused
Dnmt3L, which showed a homogenous nuclear and some weak
cytoplasmic localization (supplemental Fig. S6). We confirmed
that the CFP and YFP channels showed no cross-talk in these
experiments (supplemental Fig. S7) and studied nuclear local-
ization of Dnmt3a and Dnmt3L after co-transfection of
Dnmt3L-CFP with Dnmt3a-YFP. Dnmt3L showed weak local-
ization to heterochromatic spots in some cells, indicating some
targeting influence of Dnmt3a (Fig. 5B). This finding repro-
duces results of an earlier study (49). Interestingly, we observed
a major change in the distribution of Dnmt3a in the nucleus in
the absence and presence of Dnmt3L (Fig. 5B). When Dnmt3L
was not present, Dnmt3a was localized to the heterochromatic
foci in the great majority of cells (62%). Only a minority of cells
showed spotty Dnmt3a localization overlaid with some diffuse
background (38%), but we never observed cells with uniformly
diffused nuclearDnmt3a localizationwithout any spots. In con-
trast, in the presence of Dnmt3L, the majority of cells showed a
diffused nuclear Dnmt3a localization pattern (60%) and only a
minor fraction of cells displayed the spotty localization charac-
teristic for the wild-type Dnmt3a (15 and 25% for spotty and
spotty plus diffused, respectively).Weperformed similar exper-
iments with the Dnmt3L F261D interface mutant, which
showed strongly reduced interaction with Dnmt3a in vitro (40)
and observed a much reduced effect of the Dnmt3L variant on
the localization of Dnmt3a. In the presence of Dnmt3L F261D
the majority of cells retained the spotty or spotty and diffused
Dnmt3a localization pattern and only in a minor fraction of
cells Dnmt3a was found diffusely distributed in the nucleus.
These results indicate that Dnmt3L interaction reduces the
heterochromatic localization of Dnmt3a and redistributes it
into euchromatin.
DISCUSSION
The Dnmt3a C-terminal domain employs two interfaces for
protein/protein contacts in the structure of the Dnmt3a/
Dnmt3L heterotetrameric complex: one FF interface and one
RD interface. We show here that the FF interface also supports
self-interaction of Dnmt3a-C and that Dnmt3a-C dimers can
form protein oligomers using their RD interfaces. Since each
RD interface constitutes a potential DNA binding site, oligo-
merization of Dnmt3a creates several DNA binding sites. Our
modeling of a Dnmt3a oligomer predicted binding to several
DNAmolecules oriented next to each other roughly in parallel
(Fig. 1 and supplemental Fig. S2B). We document this unusual
mode of DNA binding to Dnmt3a-C oligomers by binding
experiments performed in solution (FRET) and imaging (SFM).
Binding of twoDNAmolecules in parallel orientation so far has
been observed only with few proteins (one noticeable example
being RecA (50)) and such DNA binding mode was not antici-
pated for Dnmt3a.
Dnmt3a has been shown to bind tightly to chromatin (21). It
is engaged in two interactions with the H3 tail, mediated by its
ADDdomain binding to the end of theH3 tail unmodified at K4
(29–30), and by its PWWP domain binding to H3K36me3,
which was found to be essential for heterochromatic localiza-
tion (31). In addition, Dnmt3a polymerizes on theDNA (38, 40)
and we show here that Dnmt3a oligomers bind to several DNA
molecules oriented in parallel. Since heterochromatin is
defined as a region of very high DNA density, the ability of
Dnmt3a oligomers to bind to parallel DNA close to each other
may contributes to the targeting of the enzyme to such DNA
dense regions. This hypothesis is supported by our finding that
heterochromatic localization of Dnmt3a was lost with non-
oligomerizing Dnmt3amutants affected at the FF interface and
in the presence of Dnmt3L, which disrupts oligomerization and
multiple DNA binding because it lacks an RD interface. The
structure of heterochromatic DNA is not known. However, at
least onemodel of the 30 nm chromatin fiber, the helical ribbon
model (51), proposes an almost parallel arrangement of the
linker DNA regions in a spacing that would fit to the model of
the Dnmt3a oligomers binding to parallel DNA molecules.
Hence, the unusual DNA binding mode of Dnmt3a could rep-
resent a novel mechanism of heterochromatic targeting.
We have shown that Dnmt3L disrupts the reversible oligo-
merization of Dnmt3a-C and it interferes with the simultane-
ous binding to several DNAmolecules to Dnmt3a. We investi-
gated the influence ofDnmt3L on the subnuclear localization of
Dnmt3a. Strikingly, more than 60% of the cells lost the hetero-
chromatic localization of Dnmt3a in the presence of Dnmt3L,
but not when Dnmt3a was co-expressed with the Dnmt3L
F261D mutant, which partially lost its ability to interact with
Dnmt3a. This observation suggests a novel mode of action of
Dnmt3L in setting DNA methylation imprints. In addition to
stimulating the activity of Dnmt3a, it might be involved in the
release of Dnmt3a from dense heterochromatin to make it
available to act at imprinted differentially methylated regions,
which are generally located in euchromatin. The expression of
Dnmt3L in germ line cells may redistribute Dnmt3a from het-
erochromatin to euchromatin and, thereby, increase Dnmt3a
availability and DNAmethylation activity for the generation of
DNA methylation imprints.
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